iSUPPLY Secures $3 Million Sharia-Compliant Financing from Bokra to Expand Healthcare Access in Egypt

Egypt-based B2B medtech platform iSUPPLY has successfully secured $3 million in Sharia-compliant, revenue-based revolving financing from Bokra, a leading digital investment platform in the MENA region. The funding will support iSUPPLY’s growth, enhance its operational scale, and improve access to medical supplies, particularly in underserved communities across Egypt.

Founded in 2022 by Ibrahim Emam, Malek Sultan, and Moustafa Zaki, iSUPPLY aims to digitize the pharmaceutical business by providing a one-stop solution to predict and address supply chain disruptions. The company leverages artificial intelligence and predictive analytics to optimize procurement and streamline inventory management, helping overcome inefficiencies in the healthcare supply chain.

Bokra’s Sharia-compliant financing model fully aligns with its goal of generating impactful, ethical investments in high-growth sectors. Ayman ElSawy, Founder and CEO of Bokra, emphasized the partnership’s potential to drive both economic and social value, providing investors with purpose-driven returns while supporting iSUPPLY’s mission to improve healthcare access across Egypt.

The partnership builds on iSUPPLY’s recent success in closing a pre-Series A round in June 2024, with participation from Disruptech Ventures, OneStop Capital, Axian Investment CVC, and Egypt Ventures, among others.

Ibrahim Emam, Co-founder and CEO of iSUPPLY, expressed enthusiasm for the collaboration, noting that this financing would allow the company to grow responsibly without diluting ownership, enabling iSUPPLY to accelerate its mission of making medicine access faster and more reliable across Egypt.

This financing deal also highlights Bokra’s commitment to expanding its portfolio of Sharia-compliant investment opportunities, with the platform aiming to bridge ethical finance with real-world impact to fuel sustainable growth in critical sectors like healthcare.

Leave a Reply

Your email address will not be published. Required fields are marked *